Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00368381 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis

StatusWithdrawn
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Why the trial stopped
Study closed for PI failure to submit renewal paperwork

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Terminated to Withdrawnv7
  2. Trial status: Withdrawn to Terminatedv5
  3. Trial status: Recruiting to Withdrawnv4
  4. Trial status: Not Yet Recruiting to Recruitingv2
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine if the combination of hydrocortisone plus fludrocortisone is more efficacious than hydrocortisone alone in treating adrenal insufficiency in severe sepsis.
Trial Details
NCT Number NCT00368381
Lead Sponsor CAMC Health System
Conditions Sepsis, Adrenal Insufficiency
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov